Recent Insights for Emerging COVID-19: Drug Discovery and Vaccine Development

Over 2.8 million confirmed COVID-19 cases worldwide are cited in this review. The paper, authored by Yuefei Zhu from Columbia University Irving Medical Center, details extensive research on drug discovery, therapeutic options, and vaccine development for COVID-19. It aggregates insights on rapid detection technologies and promising therapeutics that have mitigated the virus's transmission.

Use Cases

• Surveying current drug candidates for COVID-19 based on the review of therapeutic options.
• Analyzing the status of vaccine development based on the discussion of global institutional efforts.
• Reviewing rapid detection technologies for SARS-CoV-2 based on the description of mitigation strategies.
• Identifying research gaps in antiviral therapies based on the mention of a lack of proven effective treatments in randomized trials.

Strengths

• Cites a specific global case count of over 2.8 million confirmed COVID-19 infections.
• Authored by a researcher from a recognized medical institution, Columbia University Irving Medical Center.
• Focuses on a timely and critical global health topic with detailed discussions on multiple intervention strategies.

Limitations

• Description metadata is limited; actual data quality requires manual inspection after download.
• Last update date is unknown; freshness unverified.
• Column-level documentation is absent; field semantics must be inferred after download.

Provenance

Source

paperswithcode

Collection Method

Likely a literature review or meta-analysis of published research.

Geography

Global